CN113274452A - Traditional Chinese medicine composition for treating lumbar hyperosteogeny - Google Patents

Traditional Chinese medicine composition for treating lumbar hyperosteogeny Download PDF

Info

Publication number
CN113274452A
CN113274452A CN202110741259.1A CN202110741259A CN113274452A CN 113274452 A CN113274452 A CN 113274452A CN 202110741259 A CN202110741259 A CN 202110741259A CN 113274452 A CN113274452 A CN 113274452A
Authority
CN
China
Prior art keywords
parts
radix
traditional chinese
ginseng
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110741259.1A
Other languages
Chinese (zh)
Inventor
黄刘才
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110741259.1A priority Critical patent/CN113274452A/en
Publication of CN113274452A publication Critical patent/CN113274452A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/583—Snakes; Lizards, e.g. chameleons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732—Chaenomeles, e.g. flowering quince
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888—Pinellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8964—Anemarrhena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966—Fritillaria, e.g. checker lily or mission bells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating lumbar vertebrae hyperosteogeny. Belongs to the technical field of traditional Chinese medicines. The method comprises the following raw materials: gecko, angelica sinensis, radix angelicae sinensis, rhizoma anemarrhenae, poria cocos, pseudo-ginseng, safflower, radix rehmanniae, Chinese date, kadsura pepper stem, cortex acanthopanacis, pericarpium citri reticulatae, asarum, radix saposhnikoviae, gentiana macrophylla, thunberg fritillary bulb, schizophragma integrifolia, sweetgum vine, liquorice, ligusticum wallichii, teasel root, achyranthes bidentata, radix rehmanniae preparata, pinellia ternate, dragon's blood, caulis spatholobi, eucommia ulmoides, pawpaw, oyster, radix angelicae pubescentis and ginseng. The invention obviously improves and treats various disease conditions caused by lumbar vertebra hyperosteogeny by optimizing the formula and adopting a medicinal liquor form, improves the life quality of patients, reduces the repetition of the disease conditions and delays the development of the disease course. Meanwhile, the application range of the invention is further improved by adjusting the components of different dosage forms or medicinal liquor.

Description

Traditional Chinese medicine composition for treating lumbar hyperosteogeny
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating lumbar vertebrae hyperosteogeny.
Background
The main causes of hyperosteogeny are related to degenerative changes of articular cartilage, the hyperosteogeny of lumbar vertebra is caused by that after middle age, the physiological functions of various tissue cells of the body are gradually degenerated and aged along with the increase of the lumbar vertebra hyperosteogeny, the degenerated intervertebral disc gradually loses water, intervertebral space is narrowed, fiber ring is relaxed and expands to the periphery, the vertebral body is unstable, the fiber ring is torn outside the edge of the vertebral body, so that the nucleus pulposus protrudes, periosteum of the posterior longitudinal ligament is jacked up, new bone is generated below the fiber ring, and bony spur or hyperosteogeny is formed. Also, it is believed that after the intervertebral disc degenerates and shrinks, the vertebral body tilts forward, the anterior edge of the vertebral body is blocked by the anterior longitudinal ligament at the midline, the periosteum at the two sides is lifted, and new bone is formed under the periosteum. In addition, local stress factors are also the major factors responsible for the development of bone mass.
In the aspect of treatment, the method which is suitable for the patient is reasonably selected according to actual conditions, so that the symptoms of the patient can be effectively improved, and the normal life can be recovered. There is a need for a comprehensive understanding of the methods of prevention and treatment of lumbar hyperosteogeny. The lumbar spine spur has pathological changes such as degeneration, hyperplasia, dislocation, inflammation, autoimmune reaction and the like of structures of internal balance (lumbar vertebrae, joints, intervertebral discs and the like) and imbalance of external balance of lumbar muscles, ligaments and the like. The treatment should be done simultaneously, and both internal and external treatments should be done simultaneously. The key to treating lumbar hyperosteogeny is not to eliminate bony spur, but to eliminate aseptic inflammation around the bony spur. If there is pain, it can be treated symptomatically by antiphlogistic analgesic or closed therapy, or assisted by hot compress, physiotherapy, massage and traction to promote blood circulation, relax local muscle and relieve pain, or relieve nerve compression with small needle knife.
Western medicine has no effective treatment medicine for the disease, and adopts symptomatic treatment, for example, some antipyretic and analgesic medicines can be taken when pain occurs; the vitamin B group medicine can be selected for the numb patient. Surgical treatment is generally not the preferred treatment option.
The effect of treating hyperosteogeny by taking traditional Chinese medicines for a long time is obvious and has a long history, but how to optimize the compatibility of the prescription and improve the treatment effect needs to be continuously adjusted by combining clinical practice.
Therefore, the problem that needs to be solved urgently by the technical personnel in the field is how to provide a traditional Chinese medicine for treating lumbar vertebra hyperosteogeny, improving the treatment effect and improving symptoms.
Disclosure of Invention
In view of the above, the invention provides a traditional Chinese medicine composition for treating lumbar vertebrae hyperosteogeny.
In order to achieve the purpose, the invention adopts the following technical scheme:
a traditional Chinese medicine composition for treating lumbar vertebrae hyperosteogeny comprises the following raw materials in parts by weight: 1 to 1.5 parts of gecko, 2.5 to 3.5 parts of angelica, 1.5 to 2.5 parts of angelica sinensis, 2.5 to 3.5 parts of rhizoma anemarrhenae, 2.5 to 3.5 parts of poria cocos, 2.5 to 3.5 parts of pseudo-ginseng, 1.5 to 2.5 parts of safflower, 2.5 to 3.5 parts of radix rehmanniae, 2.5 to 3.5 parts of Chinese date, 1.5 to 2.5 parts of caulis piperis futokadsurae, 2.5 to 3.5 parts of cortex acanthopanacis, 1.5 to 2.5 parts of dried orange peel, 1.5 to 2.5 parts of asarum, 1.5 to 2.5 parts of radix sileris, 1.5 to 2.5 parts of gentiana macrophylla, 1.5 to 2.5 parts of eucommia bark, 1.5 to 2.5 parts of schizophragma integrifolium, 1.5 to 2.5 parts of radix sileris, 2.5 to 3.5 parts of liquorice, 2.5 to 3.5 parts of ligusticum wallichii, 2.5 to 2.5 parts of dipsacutum, 1.5 to 2.5 parts of radix dipsaci, 2.5 to 2.5 parts of achyranthis bidentatae, 2.5 parts of dragon's and 2.5 parts of radix angelicae pubescentis, 2.5 to 2.5 parts of radix angelicae pubescentis and 2.5 to 2.5 parts of radix angelicae pubescentis.
Preferably: the material comprises the following raw materials in parts by weight: 1 part of gecko, 3 parts of angelica sinensis, 2 parts of radix angelicae sinensis, 3 parts of rhizoma anemarrhenae, 3 parts of poria cocos, 3 parts of pseudo-ginseng, 2 parts of safflower, 3 parts of radix rehmanniae, 3 parts of Chinese date, 2 parts of kadsura pepper stem, 3 parts of cortex acanthopanacis, 2 parts of dried orange peel, 2 parts of asarum, 2 parts of radix saposhnikoviae, 2 parts of gentiana macrophylla, 2 parts of thunberg fritillary bulb, 2 parts of schizophragma integrifolium, 2 parts of sweetgum vine, 3 parts of liquorice, 3 parts of ligusticum wallichii, 3 parts of teasel root, 2 parts of achyranthes bidentata, 3 parts of prepared rehmannia root, 3 parts of pinellia ternate, 3 parts of dragon's blood, 3 parts of caulis spatholobi, 3 parts of eucommia ulmoides, 3 parts of pawpaw, 3 parts of oyster, 2 parts of radix angelicae pubescentis and 2 parts of ginseng.
Has the advantages that:
gecko: has effects in invigorating lung and kidney, promoting inspiration, relieving asthma, and promoting the flow of qi;
chinese angelica: has the effects of enriching blood, promoting blood circulation, regulating menstruation, relieving pain, and loosening bowel to relieve constipation;
end returning: has effects in promoting blood circulation, dispelling blood stasis, regulating menstruation, and relieving pain;
rhizoma anemarrhenae: has the effects of clearing heat, purging fire, nourishing yin and moistening dryness;
tuckahoe, poria cocos: has the effects of promoting diuresis, eliminating dampness, invigorating spleen, and calming heart;
pseudo-ginseng: has hemostatic, blood stasis dispelling, antiinflammatory, analgesic, and tonic effects;
safflower: has the effects of promoting blood circulation, dredging channels, removing blood stasis and relieving pain;
radix rehmanniae: has effects in clearing away heat, cooling blood, nourishing yin, and nourishing yin;
chinese date: has the effects of tonifying spleen and stomach, replenishing qi and blood, calming the heart, regulating ying and wei and harmonizing drug properties;
caulis piperis futokadsurae: has the effects of dispelling wind-damp, dredging channels and collaterals, and relieving arthralgia;
cortex acanthopanacis: has the effects of dispelling wind-damp, tonifying liver and kidney, strengthening tendons and bones, inducing diuresis and relieving swelling;
dried orange peel: has the effects of regulating qi, strengthening spleen, eliminating dampness and phlegm;
asarum: has the effects of relieving exterior syndrome, dispelling cold, dispelling pathogenic wind, relieving pain, dredging orifice, warming lung, and eliminating phlegm;
wind prevention: has the effects of relieving exterior syndrome, inducing perspiration, dispelling pathogenic wind, and removing dampness;
large-leaved gentian: has effects of dispelling pathogenic wind, removing dampness, promoting blood circulation, dredging channels, clearing heat, and promoting urination;
fritillary bulb: has the effects of clearing heat, eliminating phlegm, resolving masses and removing toxicity;
drilling the ground wind: has the effects of relaxing muscles and tendons, activating collateral flow, expelling pathogenic wind, and promoting blood circulation;
sweetgum vine (Tiger, Vitaceae plant): has effects in removing blood stasis and toxic materials;
licorice root: has the effects of regulating the drug potency, relieving the fever of spleen and stomach qi deficiency, and the like;
ligusticum wallichii: has the effects of promoting qi circulation, relieving depression, dispelling wind-dryness and dampness, promoting blood circulation and relieving pain;
teasel root: has the effects of nourishing liver and kidney, reuniting bones and muscles, and regulating blood vessels;
achyranthes root: has the effects of removing blood stasis, dredging channels, nourishing liver and kidney, strengthening tendons and bones, inducing diuresis, treating stranguria, and guiding blood downward;
prepared rhizome of rehmannia: has effects in invigorating kidney, and replenishing essence and blood;
pinellia ternata: has the effects of eliminating dampness and phlegm, lowering adverse qi and preventing vomiting, and relieving distension and fullness and dispersing accumulation of pathogen;
dragon's blood: has the effects of promoting blood circulation, relieving pain, removing blood stasis, stopping bleeding, promoting granulation, and healing wound;
caulis spatholobi: has the effects of promoting blood circulation, replenishing blood, regulating menstruation, relieving pain, relaxing muscles and tendons, and activating collaterals;
eucommia ulmoides: has effects in nourishing liver and kidney, and strengthening tendons and bones;
pawpaw: has the effects of promoting qi circulation, dissipating blood stasis, treating cardiodynia, and relieving heat stagnation;
oyster shell: has the effects of astringing yin, suppressing yang, suppressing sweating, controlling nocturnal emission, reducing phlegm and softening hard masses;
radix angelicae pubescentis: has the effects of dispelling pathogenic wind, removing dampness, relieving arthralgia and relieving pain;
ginseng: has the effects of invigorating primordial qi, restoring pulse, relieving depletion, invigorating spleen, benefiting lung, promoting fluid production, and tranquilizing.
The invention takes gecko, pubescent angelica, dragon's blood, pseudo-ginseng, ginseng and safflower as monarch drugs, firstly takes gecko and ginseng to greatly tonify primordial qi and assist essence to regulate the body state, and takes the pubescent angelica, dragon's blood, pseudo-ginseng and safflower to activate blood, dredge channels, diminish inflammation, relieve pain, promote qi circulation and dredge collaterals; chinese angelica, Chinese date, kadsura pepper stem, cortex acanthopanacis, divaricate saposhnikovia root, large-leaved gentian, schizophragma integrifolia, sweetgum vine, szechuan lovage rhizome, suberect spatholobus stem and oyster are taken as ministers, the medical condition is further improved and controlled, and the medical composition has the effects of removing rheumatism, strengthening joints, tonifying liver and kidney, promoting blood circulation, removing blood stasis and resisting inflammation; delay the progression of the degenerative disease process; the other medicinal materials are used as adjuvant drugs, so that the intestines and the stomach are conditioned, the internal circulation is promoted, and the effective ingredients of the medicaments can be conveniently and directly reach the focus. The formula is obtained by clinical practice for a long time, has obvious treatment effect and rarely causes repeated disease conditions.
The invention also provides a preparation method of the traditional Chinese medicine composition for treating lumbar vertebra hyperosteogeny, which comprises the following steps:
(1) mixing the raw materials, and adding 70-100 parts of 52-degree white spirit;
(2) soaking for more than 30 days.
Further, the white spirit can be conventional edible white spirit sold in the market.
Has the advantages that: the different preparation processes have obvious influence on the full play of the drug effect, the adoption of the medicinal liquor can fully extract the effective active ingredients of the medicinal materials, is convenient for patients to accept, and is beneficial to promoting blood circulation, dispelling wind-damp and relieving pain no matter in winter or summer.
The invention also provides application of the traditional Chinese medicine composition in preparation of medicinal liquor.
Has the advantages that: on the basis of the medicinal materials, flavoring agents can be further added into the prepared medicinal liquor or medicinal materials with homology of medicine and food can be supplemented according to the disease state, so that the medicinal effect is further improved.
The invention also provides application of the traditional Chinese medicine composition in preparation of decoction, pills, powder and capsules.
Has the advantages that: although the medicinal liquor has good effect and is convenient to take, the change of the dosage form can also play a role in treatment, and different dosage forms are suitable for different people, and pills or capsules can be taken when the people are inconvenient to go out, and the conventional preparation process is adopted.
According to the technical scheme, compared with the prior art, the traditional Chinese medicine composition for treating lumbar vertebra hyperosteogeny is disclosed, and compared with the prior art, the traditional Chinese medicine composition for treating lumbar vertebra hyperosteogeny is prepared by optimizing a formula and adopting a medicinal liquor form, so that various disease conditions caused by lumbar vertebra hyperosteogeny are remarkably improved and treated, the life quality of a patient is improved, the repetition of the disease conditions is reduced, and the development of the disease course is delayed. Meanwhile, the application range of the invention is further improved by adjusting the components of different dosage forms or medicinal liquor.
Detailed Description
The following will clearly and completely describe the technical solutions in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The embodiment of the invention discloses a traditional Chinese medicine composition for treating lumbar hyperosteogeny.
The raw materials of the traditional Chinese medicine are obtained from commercial sources, the sources of the raw materials are not limited, and the unrecited process is a conventional traditional Chinese medicine preparation process and is not repeated herein.
Example 1
A traditional Chinese medicine composition for treating lumbar vertebrae hyperosteogeny comprises the following raw materials in parts by weight: 1 part of gecko, 3.5 parts of angelica sinensis, 1.5 parts of radix angelicae sinensis, 3.5 parts of rhizoma anemarrhenae, 2.5 parts of poria cocos, 3.5 parts of pseudo-ginseng, 1.5 parts of safflower carthamus, 3.5 parts of radix rehmanniae, 2.5 parts of Chinese date, 2.5 parts of kadsura pepper stem, 2.5 parts of cortex acanthopanacis, 2.5 parts of pericarpium citri reticulatae, 1.5 parts of asarum, 2.5 parts of divaricate saposhnikovia root, 1.5 parts of gentiana macrophylla, 2.5 parts of thunberg fritillary bulb, 1.5 parts of schizophragma integrifolium, 1.5 parts of sweetgum twig, 3.5 parts of liquorice, 2.5 parts of ligusticum wallichii, 3.5 parts of teasel root, 1.5 parts of achyranthes bidentata, 3.5 parts of prepared rhizome of rehmannia, 2.5 parts of pinellia ternate, 3.5 parts of dragon's blood, 2.5 parts of caulis spatholobi, 3.5 parts of eucommia ulmoides, 2.5 parts of pawpaw, 3.5 parts of oyster, 1.5 parts of radix angelicae pubescentis and 2.5 parts of ginseng.
The preparation method is characterized by comprising the following steps:
(1) mixing the raw materials, and adding 70 parts of 52-degree white spirit;
(2) and soaking for 30 d.
Example 2
A traditional Chinese medicine composition for treating lumbar vertebrae hyperosteogeny comprises the following raw materials in parts by weight: 1 part of gecko, 3 parts of angelica sinensis, 2 parts of radix angelicae sinensis, 3 parts of rhizoma anemarrhenae, 3 parts of poria cocos, 3 parts of pseudo-ginseng, 2 parts of safflower, 3 parts of radix rehmanniae, 3 parts of Chinese date, 2 parts of kadsura pepper stem, 3 parts of cortex acanthopanacis, 2 parts of dried orange peel, 2 parts of asarum, 2 parts of radix saposhnikoviae, 2 parts of gentiana macrophylla, 2 parts of thunberg fritillary bulb, 2 parts of schizophragma integrifolium, 2 parts of sweetgum vine, 3 parts of liquorice, 3 parts of ligusticum wallichii, 3 parts of teasel root, 2 parts of achyranthes bidentata, 3 parts of prepared rehmannia root, 3 parts of pinellia ternate, 3 parts of dragon's blood, 3 parts of caulis spatholobi.
The preparation method is characterized by comprising the following steps:
(1) mixing the raw materials, and adding 80 parts of 52-degree white spirit;
(2) and soaking for 40 d.
Example 3
A traditional Chinese medicine composition for treating lumbar vertebrae hyperosteogeny comprises the following raw materials in parts by weight: 1.5 parts of gecko, 2.5 parts of angelica sinensis, 2.5 parts of radix angelicae sinensis, 2.5 parts of rhizoma anemarrhenae, 3.5 parts of poria cocos, 2.5 parts of pseudo-ginseng, 2.5 parts of safflower carthamus, 3.5 parts of radix rehmanniae, 3.5 parts of Chinese date, 1.5 parts of kadsura pepper stem, 3.5 parts of cortex acanthopanacis, 1.5 parts of pericarpium citri reticulatae, 2.5 parts of asarum, 1.5 parts of radix sileris, 2.5 parts of gentiana macrophylla, 1.5 parts of thunberg fritillary bulb, 2.5 parts of schizophragma integrifolium, 1.5 parts of sweetgum stem, 3.5 parts of liquorice, 2.5 parts of ligusticum wallichii, 2.5 parts of teasel root, 1.5 parts of radix achyranthis bidentatae, 3.5 parts of prepared rhizome of rehmannia, 2.5 parts of pinellia ternate, 3.5 parts of dragon's blood, 3.5 parts of caulis spatholobi, 2.5 parts of eucommia ulmoides, 3.5 parts of pawpaw, 2.5 parts of oyster, 2.5 parts of radix angelicae pubescentis and 2.5 parts of ginseng.
The preparation method is characterized by comprising the following steps:
(1) mixing the raw materials, and adding 70-100 parts of 52-degree white spirit;
(2) and soaking for 35 d.
Comparative experiment
Group 1: the same as in example 2.
And 2, group: the monarch drug is adjusted, gecko and pubescent angelica root are omitted, 1.5 parts of cyperus rotundus and 2.5 parts of myrrh are respectively substituted for the monarch drug, the dosage of the ministerial drug is reduced by 1/3, and the rest is the same as the example 2.
And 3, group: the preparation method is the same as that of example 2, and adopts a compatible formula of 3 parts of divaricate saposhnikovia root, 3 parts of fineleaf schizonepeta herb, 2 parts of szechuan lovage rhizome, 3 parts of clematis root, 3 parts of chrysanthemum, 3 parts of manchurian wildginger, 3 parts of Chinese angelica, 4 parts of incised notopterygium rhizome, 4 parts of ligusticum sinense oliver, 4 parts of cassia twig, 2 parts of kudzuvine root, 3 parts of liquoric root, 3 parts of prepared rehmannia root, 2 parts of dogwood fruit, 3 parts of common yam rhizome, 2 parts of oriental waterplantain rhizome, 2 parts of doubleteeth pubescent angelica root, 2 parts of tree peony root bark, 2 parts of Indian buead, 3 parts of large-leaved gentian, 2 parts of twotooth achyranthes root, 2 parts of common floweringquince fruit and 4 parts of oyster.
45 patients with lumbar hyperosteogeny and confirmed diagnosis with the condition close to that of the patients with lumbar hyperosteogeny of 45-65 years old and the average course of disease longer than 3 years are screened by adopting a visual simulation scoring method, the patients are averagely and randomly divided into 3 groups, the 1-3 groups of treatment schemes are respectively adopted for intervention treatment (the medicinal liquor prepared by each group is drunk half a day at night and is continuously drunk for 15 days), and meanwhile, the conventional hot compress physical therapy is adopted.
Wherein, the VAS score is set as follows:
selecting a moving scale with the length of 10cm, sequentially taking 0-10 ends as painless to severe pain, and evaluating scores by doctors according to feedback of patients;
and (3) curing: 0 minute;
the effect is shown: a treated VAS score of less than 4 points;
the method has the following advantages: scoring for 4-6 points by treatment VAS;
and (4) invalidation: upon treatment, the VAS score was greater than 6 points.
The statistical results show that:
1 group has 14 healed people and 1 obvious effect;
2 groups cure 8 people, show 5 people and 2 people;
the 3 groups cure 9 persons, the effective number is 3 persons, the effective number is 2 persons, and the ineffective number is 1 person.
After the treatment is finished, no drug intervention is carried out, the physical therapy is maintained, and the recurrence condition is counted after 1 year, namely 1 group of 0 people, 2 groups of 4 people and 3 groups of 3 people.
The formula of the invention is obtained by years of clinical practice, has reasonable compatibility, fully utilizes the effective active ingredients of the medicine, cures the lumbar hyperosteogeny more completely and clinically, and plays a positive role in delaying the development of the disease state.
The embodiments in the present description are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.

Claims (5)

1. A traditional Chinese medicine composition for treating lumbar vertebrae hyperosteogeny is characterized by comprising the following raw materials in parts by weight: 1 to 1.5 parts of gecko, 2.5 to 3.5 parts of angelica, 1.5 to 2.5 parts of angelica sinensis, 2.5 to 3.5 parts of rhizoma anemarrhenae, 2.5 to 3.5 parts of poria cocos, 2.5 to 3.5 parts of pseudo-ginseng, 1.5 to 2.5 parts of safflower, 2.5 to 3.5 parts of radix rehmanniae, 2.5 to 3.5 parts of Chinese date, 1.5 to 2.5 parts of caulis piperis futokadsurae, 2.5 to 3.5 parts of cortex acanthopanacis, 1.5 to 2.5 parts of dried orange peel, 1.5 to 2.5 parts of asarum, 1.5 to 2.5 parts of radix sileris, 1.5 to 2.5 parts of gentiana macrophylla, 1.5 to 2.5 parts of eucommia bark, 1.5 to 2.5 parts of schizophragma integrifolium, 1.5 to 2.5 parts of radix sileris, 2.5 to 3.5 parts of liquorice, 2.5 to 3.5 parts of ligusticum wallichii, 2.5 to 2.5 parts of dipsacutum, 1.5 to 2.5 parts of radix dipsaci, 2.5 to 2.5 parts of achyranthis bidentatae, 2.5 parts of dragon's and 2.5 parts of radix angelicae pubescentis, 2.5 to 2.5 parts of radix angelicae pubescentis and 2.5 to 2.5 parts of radix angelicae pubescentis.
2. The traditional Chinese medicine composition for treating lumbar vertebra hyperosteogeny according to claim 1, which comprises the following raw materials in parts by weight: 1 part of gecko, 3 parts of angelica sinensis, 2 parts of radix angelicae sinensis, 3 parts of rhizoma anemarrhenae, 3 parts of poria cocos, 3 parts of pseudo-ginseng, 2 parts of safflower, 3 parts of radix rehmanniae, 3 parts of Chinese date, 2 parts of kadsura pepper stem, 3 parts of cortex acanthopanacis, 2 parts of dried orange peel, 2 parts of asarum, 2 parts of radix saposhnikoviae, 2 parts of gentiana macrophylla, 2 parts of thunberg fritillary bulb, 2 parts of schizophragma integrifolium, 2 parts of sweetgum vine, 3 parts of liquorice, 3 parts of ligusticum wallichii, 3 parts of teasel root, 2 parts of achyranthes bidentata, 3 parts of prepared rehmannia root, 3 parts of pinellia ternate, 3 parts of dragon's blood, 3 parts of caulis spatholobi, 3 parts of eucommia ulmoides, 3 parts of pawpaw, 3 parts of oyster, 2 parts of radix angelicae pubescentis and 2 parts of ginseng.
3. A preparation method of a traditional Chinese medicine composition for treating lumbar vertebra hyperosteogeny is characterized by comprising the following steps:
(1) mixing the raw materials according to claim 1 or 2, and adding 70-100 parts of 52-degree white spirit;
(2) soaking for more than 30 days.
4. Use of the Chinese medicinal composition of claim 1 or 2 in the preparation of a medicated wine.
5. Use of the Chinese medicinal composition of claim 1 or 2 in the preparation of decoction, pill, powder, capsule.
CN202110741259.1A 2021-06-30 2021-06-30 Traditional Chinese medicine composition for treating lumbar hyperosteogeny Pending CN113274452A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110741259.1A CN113274452A (en) 2021-06-30 2021-06-30 Traditional Chinese medicine composition for treating lumbar hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110741259.1A CN113274452A (en) 2021-06-30 2021-06-30 Traditional Chinese medicine composition for treating lumbar hyperosteogeny

Publications (1)

Publication Number Publication Date
CN113274452A true CN113274452A (en) 2021-08-20

Family

ID=77286266

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110741259.1A Pending CN113274452A (en) 2021-06-30 2021-06-30 Traditional Chinese medicine composition for treating lumbar hyperosteogeny

Country Status (1)

Country Link
CN (1) CN113274452A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101869676A (en) * 2010-06-01 2010-10-27 毛成艺 Medicinal liquor for treating cold and dampness
CN102058823A (en) * 2009-09-21 2011-05-18 王解清 Traditional Chinese medicine preparation for treatment of prolapse and hyperplasia of human cervical and lumbar vertebra
CN111166813A (en) * 2019-11-29 2020-05-19 菏泽市圣医医疗科技有限公司 Traditional Chinese medicine for treating lumbar spondylosis and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058823A (en) * 2009-09-21 2011-05-18 王解清 Traditional Chinese medicine preparation for treatment of prolapse and hyperplasia of human cervical and lumbar vertebra
CN101869676A (en) * 2010-06-01 2010-10-27 毛成艺 Medicinal liquor for treating cold and dampness
CN111166813A (en) * 2019-11-29 2020-05-19 菏泽市圣医医疗科技有限公司 Traditional Chinese medicine for treating lumbar spondylosis and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张继元: "独活寄生汤临床应用心得", 《中医正骨》 *

Similar Documents

Publication Publication Date Title
CN104324093B (en) A kind of Chinese medicine composition treating hyperosteogeny and preparation method thereof
CN104721426A (en) Traditional Chinese medicine composition for promoting fracture healing
CN105434962A (en) Chinese herbal preparation for treating thoracolumbar vertebral fracture and preparation method of Chinese herbal preparation
CN105343442A (en) External medicament for treating lubar intervertebral disc protrusion and preparation method thereof
CN105031013A (en) Medicine for treating lumbar vertebrae bone hyperplasia and preparation method thereof
CN103751301B (en) For the goods of aseptic necrosis of femoral head patient
CN104524524B (en) Medicine treating osteoporosis and preparing method
CN106511905A (en) Traditional Chinese medicine preparation used for curing cervical spondylosis and preparation method thereof
CN102743550B (en) Medicine composition for accelerating healing after fracture surgery, preparation method and application
CN113274452A (en) Traditional Chinese medicine composition for treating lumbar hyperosteogeny
CN111358915A (en) Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof
CN104524080A (en) Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method
CN112755134B (en) Plaster for treating hyperosteogeny and preparation method thereof
CN103301401A (en) Medicated wine and preparation method thereof
CN109125544A (en) A kind of external application bone-setting ointment and preparation method thereof
CN101897822B (en) Traditional Chinese medicinal preparation for treating hyperosteogeny and prolapse of intervertebral discs and preparation method thereof
CN107184773A (en) A kind of pharmaceutical formulation for treating backbone retrogression pathological changes
CN106474325A (en) A kind of Chinese medicine preparation for treating cervical spondylopathy and waist dish outstanding and preparation method thereof
CN105998260A (en) Traditional Chinese preparation for treating injury of knee joint meniscus and preparation method
CN106421255A (en) Topical traditional Chinese composition and its application
CN104758830A (en) Traditional Chinese medicine composition for treating bone disease and skin injury and preparation method of traditional Chinese medicine composition
CN104840840A (en) Traditional Chinese medicine external lotion for treating calcaneodynia and preparation method
CN104383366B (en) A kind of Chinese medicine composition for treating osteoproliferation
CN1075948C (en) Complete medicine zhuibikang' for treating protrusion of intervertebral disc and preparing process thereof
CN110755596A (en) A plaster for treating rheumatism, rheumatoid disease and traumatic injury

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210820

RJ01 Rejection of invention patent application after publication